Pure Global AI
MHLW Document

MHLW FY2025 national pharmaceutical-affairs meeting — reference materials

令和7年度全国薬務関係主管課長会議(参考資料)— complete 77-page Medical Device Evaluation Division reference
JapanMinistry of Health, Labour and Welfare — Pharmaceutical Safety Bureau, Medical Device Evaluation DivisionRegistrationCurrentness under review
Document status

Currentness under review. Whether this instrument remains applicable is under review. Consult the later instruments and source context below before relying on it.

Document identity

令和7年度全国薬務関係主管課長会議(参考資料)— complete 77-page Medical Device Evaluation Division reference is published by Ministry of Health, Labour and Welfare — Pharmaceutical Safety Bureau, Medical Device Evaluation Division. This document is identified by its title; no separate official document code is recorded.

Instrument
Document
Full name
MHLW FY2025 national pharmaceutical-affairs meeting — reference materials
Category
Registration
Source links
Source publication
Japanese
Linked source text; confirm the publisher, publication details and any later amendment or consolidated version.
Readable HTML
1 language version
Direct citations can link to a specific article or section by appending its fragment identifier.
Dates
Published
—
Effective
—
Readable full text

Open a language version

Each version has stable passage anchors for direct citations and highlighting. The readable text is generated from an authority source and does not replace the legally controlling publication.

About this regulation

令和7年度全国薬務関係主管課長会議(参考資料)— complete 77-page Medical Device Evaluation Division reference

Complete 77-page official FY2025 national pharmaceutical-affairs meeting reference PDF issued by the MHLW Medical Device Evaluation Division. Cover and contents are preserved at physical pages 1–2; the 2024 medical-device collaborative review plan is physical pages 3–5 and the separate 2024 IVD plan is pages 6–7. The MD plan section 8 at pages 4–5 states cohort 80th-percentile review targets, including four months for the specified partial-change approval branch; it is not a statutory deadline or a complete elapsed time for every change, transfer or IVD scenario. The IVD plan has its own target branches and is not assigned the MD four-month target. All remaining source reference sections are retained, including regenerative-medicine context, device statistics, certification bodies, cybersecurity and international-regulatory cooperation; their presence does not make each section a device-change obligation. Many pages are scanned or have native text limited to page numbers: all 77 original page images govern, and the unchanged native layer is expressly incomplete for searching rather than silently corrected, OCR-reconstructed or called blank. The document cover gives FY2025, not an exact publication/effective date; no such date or current-law status is inferred. Reuses the exact historical official GET of 20 October 2026 without a fresh retrieval claim.

This document is identified by its title; no separate official document code is recorded. Always confirm the current consolidated text and transition provisions with the official source before filing.